TNFalfa Blocking Treatment of Spondylarthropathies

Sponsor
Hvidovre University Hospital
Study ID
NCT00133315
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Infliximab — DRUG
  • Etanercept — DRUG
  • Adalimumab — DRUG

Study Details

The purpose of the study is to establish a Danish cohort of spondylarthropathy (SpA) patients who are being treated with TNFalfa blockers. By following the TNFalfa blocking treated patients the researchers want to identify better biomarkers for disease activity and disease progression. In addition, the researchers want to identify predictors for disease progression.

Key Dates

Start date
Sep 30, 2004
Status verified
Apr 2007
Completion
Apr 30, 2007

Study Design

Enrollment
50 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Related Studies